|
Setting Standards with New Generation Therapies! The ITM Group provides a new generation of highly effective radioisotope therapies and integrated application systems to those oncological and endovascular patients who are currently very difficult or impossible to treat with conventional methods:
|
|
Read more...
|
|
|
The ITM Group collaborates globally with leading partners in the development, production and application of radioisotopes.
|
|
Read more...
|
|
The development of the ITM product portfolio and technologies has been largely made possible and continues to be driven by the exceptional, multidisciplinary combination of human resources and technological infrastructure in the Garching/Munich environment.
|
|
Read more...
|
|
|
The new generation of personalized therapies, combining advances in bio-technology with radioisotopes, not only significantly improves the outcomes of therapies in oncology
|
|
Read more...
|
|
In 2004 the founders of ITM AG were approached by leading medical and academic institutions with requests to collaborate in the development and industrialization of a new generation of (personalized) radioisotope therapies.
|
|
Read more...
|
|
|
